Cornerstone Therapeutics Inc. (CRTX) provided financial guidance for the year ending December 31, 2010.
The company anticipates net revenues in excess of $112 million in 2010. This estimate assumes that revenue contribution from branded products will increase from 40% of net revenues in 2009 to in excess of 75% of net revenues in 2010.
The company also expects GAAP net income for the year in excess of $0.6 million or $0.02 per share. Non-GAAP net income is expected in excess of $10.2 million or $0.38 per share.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.